Is Wegovy FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. Each entry is based on publicly available information from the U.S. Food and Drug Administration and other authoritative sources. This page explains whether Wegovy is FDA approved and how it is commonly categorized.
Overview
Wegovy is a brand-name semaglutide medication. It belongs to the GLP-1 receptor agonist drug class and is used in approved prescription treatment settings for chronic weight management and certain cardiovascular risk reduction uses.
FDA Status Details
Wegovy is classified as FDA Approved. Approval status applies to the specific FDA-approved Wegovy product, labeled dosage forms, manufacturer, and approved indications.
Brand Names & Variants
Wegovy is the brand name. Its active ingredient is semaglutide. Other FDA-approved semaglutide products include Ozempic and Rybelsus, but those products have different labeling, dosage forms, and approved uses.
Compounded & Private Label Considerations
Wegovy should not be confused with compounded semaglutide, private-label semaglutide, or online-marketed semaglutide products. Compounded versions are not FDA-approved equivalents of Wegovy.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.